Free Trial

Sanders Morris Harris LLC Grows Stock Position in Docusign Inc. $DOCU

Docusign logo with Computer and Technology background

Key Points

  • Sanders Morris Harris LLC significantly increased its stake in Docusign Inc. by 496.5% in Q2, acquiring 14,150 additional shares to bring its total to 17,000 shares, valued at approximately $1.32 million.
  • Several institutional investors have also enhanced their positions in Docusign, showing increasing interest, with hedge funds currently holding 77.64% of the company's stock.
  • Recent analyst upgrades, including a move from "hold" to "buy" and increased price targets, indicate a positive sentiment around Docusign, which has a current consensus rating of "Hold" and an average price target of $94.14.
  • Interested in Docusign? Here are five stocks we like better.

Sanders Morris Harris LLC increased its holdings in Docusign Inc. (NASDAQ:DOCU - Free Report) by 496.5% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 17,000 shares of the company's stock after acquiring an additional 14,150 shares during the period. Sanders Morris Harris LLC's holdings in Docusign were worth $1,324,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in DOCU. Banque Transatlantique SA purchased a new position in shares of Docusign during the 1st quarter worth $26,000. Hemington Wealth Management lifted its position in Docusign by 318.1% in the first quarter. Hemington Wealth Management now owns 347 shares of the company's stock valued at $28,000 after buying an additional 264 shares during the last quarter. Golden State Wealth Management LLC boosted its stake in Docusign by 519.4% during the first quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock worth $31,000 after buying an additional 322 shares during the period. Summit Securities Group LLC purchased a new position in Docusign during the first quarter worth about $34,000. Finally, Rise Advisors LLC increased its position in shares of Docusign by 864.6% during the first quarter. Rise Advisors LLC now owns 463 shares of the company's stock valued at $38,000 after acquiring an additional 415 shares during the last quarter. Hedge funds and other institutional investors own 77.64% of the company's stock.

Wall Street Analysts Forecast Growth

DOCU has been the topic of several recent analyst reports. Wall Street Zen upgraded shares of Docusign from a "hold" rating to a "buy" rating in a report on Saturday, September 13th. Citigroup boosted their target price on Docusign from $110.00 to $115.00 and gave the company a "buy" rating in a research report on Thursday, September 4th. UBS Group set a $95.00 price target on Docusign in a research report on Friday, September 5th. Piper Sandler lifted their price objective on Docusign from $85.00 to $90.00 and gave the company a "neutral" rating in a research note on Friday, September 5th. Finally, Wells Fargo & Company boosted their price objective on Docusign from $80.00 to $85.00 and gave the company an "equal weight" rating in a report on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and fifteen have issued a Hold rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $94.14.

Read Our Latest Stock Analysis on DOCU

Insider Transactions at Docusign

In other news, CEO Allan C. Thygesen sold 40,000 shares of Docusign stock in a transaction on Wednesday, October 1st. The shares were sold at an average price of $69.69, for a total transaction of $2,787,600.00. Following the completion of the sale, the chief executive officer directly owned 136,246 shares of the company's stock, valued at approximately $9,494,983.74. The trade was a 22.70% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Blake Jeffrey Grayson sold 6,500 shares of the business's stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $71.20, for a total transaction of $462,800.00. Following the transaction, the chief financial officer owned 105,660 shares of the company's stock, valued at approximately $7,522,992. The trade was a 5.80% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 102,533 shares of company stock valued at $7,709,933 over the last quarter. Insiders own 1.66% of the company's stock.

Docusign Trading Up 4.0%

Shares of NASDAQ DOCU opened at $70.68 on Tuesday. The stock has a market cap of $14.21 billion, a P/E ratio of 53.14, a PEG ratio of 3.38 and a beta of 1.02. The business's fifty day simple moving average is $75.09 and its 200-day simple moving average is $77.92. Docusign Inc. has a 12-month low of $66.35 and a 12-month high of $107.86.

Docusign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings results on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.08. The company had revenue of $800.64 million for the quarter, compared to the consensus estimate of $780.35 million. Docusign had a return on equity of 14.01% and a net margin of 9.08%.Docusign's revenue was up 8.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.97 EPS. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. On average, equities analysts forecast that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign Company Profile

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Featured Stories

Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU - Free Report).

Institutional Ownership by Quarter for Docusign (NASDAQ:DOCU)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Docusign Right Now?

Before you consider Docusign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.

While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.